Vitalipid N child (Vitalipid N Infant)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceMultivitamins [parenteral administration]Multivitamins [parenteral administration]
Similar drugsTo uncover
  • Beviplex
    lyophilizate w / m in / in 
    Galenika ad.     Yugoslavia
  • Vitalipid H adult
    emulsion d / infusion 
    Fresenius Kabi Deutschland GmbH     Germany
  • Vitalipid N child
    emulsion d / infusion 
    Fresenius Kabi Deutschland GmbH     Germany
  • Cernevit
    lyophilizate in / in 
    Baxter, C.A.     Belgium
    • Dosage form: & nbspemulsion for infusions
    Composition:

    1 ml of emulsion for infusion contains:

    Active components:


    Retinol palmitate (corresponding to retinol 69 μg)

    135.3 μg

    Phytomenadione

    20 μg

    Ergocalciferol

    1.0 μg

    Alfa-tocopherol

    0.64 mg

    Excipients:

    Soybean oil beans

    100 mg

    Phospholipids of egg yolk

    12 mg

    Glycerol anhydrous

    22 mg

    Sodium hydroxide 1M *

    up to pH 8

    Water for injections

    up to 1 ml
    * is a pH corrector and does not bear the label of the ampoule and cardboard pack
    Description:

    White homogeneous emulsion.

    Pharmacotherapeutic group:Multivitamins
    ATX: & nbsp

    A.11.B.A   Multivitamins

    Pharmacodynamics:

    Pharmacological properties of the drug are due to the properties of the fat-soluble vitamins in its composition. VITALIPID H child is a mixture of vitamins in amounts consumed with a normal diet, and should not have any pharmacodynamic effects other than restoring and maintaining a normal level of vitamins A, D2, E, K1.

    Indications:

    VITALIPID H child Used in newborns and children under 11 years of age to provide a daily requirement for fat-soluble vitamins A, D2, E, K1 with parenteral nutrition.

    Contraindications:

    Increased individual sensitivity to the components of the drug; diseases that occur with a violation of the metabolism of fats, such as renal insufficiency, decompensated diabetes mellitus, pancreatitis, impaired liver function, hypothyroidism (if hypertriglyceridemia is noted) and severe sepsis. In such patients in the case of the use of Vitalipida H children should carefully monitor the level of triglycerides in the serum.

    Hypersensitivity to soy and egg proteins.

    Dosing and Administration:

    Intravenously.

    Before using Vitalipid H, the baby should be diluted. All manipulations should be carried out under aseptic conditions.

    For newborns weighing less than 2.5 kg (premature or children with low birth weight), the daily dose is 4 ml / kg body weight Vitalipid H child per day.

    For the remaining children under the age of 11, the drug is prescribed in a dose of 10 ml (one ampoule) per day.

    1 hour prior to the onset of infusion in aseptic conditions, 10 ml (one ampoule) of the drug Vitalipid N children is added to 500 ml of Intralipid 10% and 20%.

    The resulting solution is agitated lightly, then used for parenteral infusion according to the instructions for use of Intralipid. The resulting solution must be used within 24 hours.

    Side effects:

    Against the background of infusion of Vitalipida N, all the side reactions characteristic of fat emulsion can occur in children.

    Interaction:

    Vitalipid N children contains vitamin K1, which can interact with coumarinic anticoagulants.

    Special instructions:

    Vitalipid N children can only be used diluted.

    Form release / dosage:

    Emulsion for infusion.

    Packaging:

    For 10 ml of emulsion in a vial of transparent glass.

    10 ampoules in a contour squamous package.

    1 circuit cell pack with instructions for use is placed in a cardboard box.

    Storage conditions:

    Store in a dark place at a temperature of no higher than 25 ° C. Do not freeze!

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after expiry date.

    Terms of leave from pharmacies:On prescription
    Registration number:П N014643 / 01
    Date of registration:04.04.2008
    Expiration Date:Unlimited
    The owner of the registration certificate:Fresenius Kabi Deutschland GmbHFresenius Kabi Deutschland GmbH Germany
    Manufacturer: & nbsp
    Representation: & nbspFRESENIUS KABI DEYCHLAND GmbH FRESENIUS KABI DEYCHLAND GmbH Germany
    Information update date: & nbsp21.02.2017
    Illustrated instructions
      Instructions
      Up